本页面由Tiger Trade Technology Pte. Ltd.提供服务

Allogene Therapeutics Inc.

1.40
-0.0600-4.11%
盘后:1.410.0100+0.71%19:30 EDT
成交量:431.65万
成交额:609.39万
市值:4.83亿
市盈率:-2.15
高:1.46
开:1.45
低:1.39
收:1.46
52周最高:4.46
52周最低:1.04
股本:3.45亿
流通股本:2.84亿
量比:0.68
换手率:1.52%
股息:- -
股息率:- -
每股收益(TTM):-0.6510
每股收益(LYR):-0.8652
净资产收益率:-42.39%
总资产收益率:-22.08%
市净率:1.11
市盈率(LYR):-1.62

数据加载中...

2024/03/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/14

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

重要事件披露

Form 8-K - Current report
2024/03/14

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/02/23

SEC问询函

Form CORRESP - Correspondence
2024/02/16

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

重要事件披露

Form 8-K - Current report
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/05

重要事件披露

Form 8-K - Current report
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/16

SEC问询函

Form CORRESP - Correspondence
2023/11/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/02

重要事件披露

Form 8-K - Current report
2023/10/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/18

重要事件披露

Form 8-K/A - Current report: [Amend]